Format

Send to

Choose Destination
Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30.

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

Author information

1
Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano (CS), Italy.
2
Department of Medicine, Division of Hematology, Stanford University, California.
3
Hematology Unit, Department of Onco-hematology, A.O. of Cosenza, Cosenza, Italy.
4
Hematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
5
Hematology, Department of Cellular Biotechnologies and Hematology, 'Sapienza' University, Rome, Italy.
6
Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
7
Unità di Ematologia, Ospedale Vito Fazzi, Lecce, Italy.
8
Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
9
Department of Hematology, Ospedale Santo Spirito, Pescara, Italy.
10
Division of Hematology, AOU Policlinico-OVE, University of Catania, Catania, Italy.
11
UO Molecular Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
12
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
13
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota.
14
Consiglio Nazionale delle Ricerche, Istituto di Biomedicina ed Immunologia Molecolare, Reggio Calabria, Italy.
15
Division of Haematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
16
Department of Experimental Medicine, University of Genova, Genoa, Italy.
PMID:
29984867
DOI:
10.1002/ajh.25206
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center